Sildenafil for women patients with antidepressant-induced sexual dysfunction
Sildenafil is also available under the brand Revatio at lower doses for pulmonary hypertension in both sexes.
| Benefit | Explanation | Evidence Level | Notes |
|---|---|---|---|
| Improved Blood Flow | Enhances genital blood circulation | Moderate | May aid sexual arousal |
| Increased Libido | Possible enhancement of sexual desire | Limited | Varies among women |
| Better Orgasm Response | Some reports of improved orgasm | Anecdotal | Not scientifically proven |
| Enhanced Clitoral Sensitivity | Possible increase in sensation | Theoretical | Needs more research |
Some trials suggest benefit for women with arousal problems or SSRI‑induced sexual side effects, particularly in postmenopausal women.
- Discussions with healthcare providers are crucial before considering sildenafil.
- Female sexual dysfunction may have hormonal, psychological, or physical causes.
- Sildenafil should never be used with other medications without medical approval.
- Its use in women should be part of a broader treatment plan.
Other studies show minimal or no improvement. More research is needed to determine which subgroups of women might benefit.
What special precautions should I follow?
Speak to your doctor about how drug interactions should be managed. Sildenafil is metabolized mainly by CYP3A4 and to some extent by CYP2C9. It also weakly inhibits CYP1A2, 2C(, 2C19, 2D^, 2E1, and 3A4. Any drug that is a substrate of one of these enzymes could potentially interact with sildenafil. In addition, taking sildenafil with too much alcohol can lead to orthostatic hypotension, which is a drop in blood pressure when you go from a sitting or lying down position to standing.
Polymer-based nitric oxide therapies: Recent insights for biomedical applications
Symptoms include a headache, dizziness, or fainting when standing. Antacids, such as magnesium hydroxide or aluminum hydroxide may also affect the absorption of sildenafil. Grapefruit juice may also increase the side effects of sildenafil. Note that this list is not all-inclusive and includes only common medications that may interact with sildenafil. You should refer to the prescribing information for sildenafil for a complete list of interactions.
Knowledge Gaps in Urologic Care of Female Spinal Cord Injury Patients
Cialis vs Viagra - What's the difference between them? Do you know these 11 amazing facts about Viagra? Is generic Viagra available in the U.S.? Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use sildenafil only for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Allergic reactions: hives, facial or throat swelling, difficulty breathing Heart problems: chest pain, heart attack, irregular heartbeat Dangerous drop in blood pressure when combined with nitrates (nitroglycerin, isosorbide dinitrate) or certain blood pressure medications Prolonged erection (priapism) lasting more than 4 hours Addyi (flibanserin): taken daily at bedtime for premenopausal women with hypoactive sexual desire disorder. Side effects include dizziness, fatigue, nausea, dry mouth, and insomnia.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 150mg | 90 + 6 Pills | 147.18€ 140.17€ | |
| Viagra Generic | 150mg | 10 Pills | 36.73€ 34.98€ | |
| Viagra Generic | 200mg | 60 + 4 Pills | 125.19€ 119.23€ | |
| Viagra Generic | 150mg | 60 + 4 Pills | 111.25€ 105.95€ | |
| Kamagra | 100mg | 360 + 6 Pills | 839.95€ 799.95€ | |
| Kamagra Polo | 100mg | 60 + 4 Pills | 189.39€ 180.37€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Viagra Generic | 50mg | 10 Pills | 26.87€ 25.59€ | |
| Viagra Generic | 50mg | 90 + 6 Pills | 107.37€ 102.26€ | |
| Kamagra Polo | 100mg | 272 + 12 Pills | 622.94€ 593.28€ | |
| Kamagra Soft Tabs | 100mg | 272 + 12 Pills | 593.42€ 565.16€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ | |
| Kamagra Oral Jelly | 100mg | 30 + 5 Sachets | 136.20€ 129.71€ | |
| Viagra Generic | 200mg | 120 + 8 Pills | 204.80€ 195.05€ |
Vyleesi (bremelanotide): injected at least 45 minutes before sexual activity, up to 8 doses per month, for premenopausal women with low desire.
Related topics
Quirk F, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women sildenafil products over the counter with sexual dysfunction. Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. Berman JR, Berman LA, Toler SM, Gill J, Haughie S.
Authors and Affiliations
Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. Female sexual dysfunction (FSD) affects up to one third of women in the U.S., often involving low libido, arousal difficulties, and pain during intercourse. Viagra (sildenafil citrate) is approved to treat erectile dysfunction in men but is sometimes prescribed off‑label in women. Evidence is limited and mixed, and FSD often has multifactorial causes including hormonal changes, medications, relationship issues, and psychological factors. By blocking PDE‑5, it increases blood flow to genital tissues: In women, enhanced blood flow to the clitoris and labia may increase lubrication, sensitivity, and genital engorgement following sexual stimulation. Common side effects are nausea, flushing, injection site reactions, headache, and fatigue. Avoiding tobacco, excess alcohol, and recreational drugs Investigational supplements (L‑arginine, ginseng, maca, etc.) have limited evidence Safety and efficacy of sildenafil citrate in women with arousal disorder. Prevalence of low sexual desire in US women. This post was written with Consensus AI Academic Search Engine - please read our Disclaimer at the end of this article. The concept of a 'Female Viagra' has garnered significant attention in recent years, as researchers and pharmaceutical companies seek to address sexual dysfunction in women.
- Common side effects in women may include dizziness and nasal congestion.
- Women should avoid it if they are pregnant or breastfeeding.
- Combining sildenafil with nitrates can cause dangerous drops in blood pressure.
- It is important to follow prescribed dosages strictly.
Sildenafil citrate, commonly known as Viagra, is well-known for its efficacy in treating erectile dysfunction in men. However, its potential benefits for women with sexual dysfunction, particularly Female Sexual Arousal Disorder (FSAD), remain a topic of ongoing research and debate.
6. Response and effectiveness
Some benefits, especially in ability to achieve orgasm, were reported. Men and women who take selective or nonselective serotonin reuptake inhibitors (SRIs) commonly report sexual dysfunction; the main difficulties among women are orgasmic dysfunction and problems with arousal, including lubrication. Studies of selective phosphodiesterase type 5 inhibitors (sildenafil [Viagra], vardenafil [Levitra], and tadalafil [Cialis]) as therapy for women with sexual arousal disorder have produced mixed results. In this multisite trial, funded by sildenafil´s manufacturer, researchers enrolled 98 women (mean age, 37) who had normal sexual function before treatment for depression, were being treated successfully with SRIs (usually fluoxetine, sertraline, or paroxetine; mean treatment time, 28 months), and had substantial sexual dysfunction associated with antidepressant use; they were randomized to sildenafil (50-100 mg) or to placebo; drugs were taken 1 to 2 hours before anticipated sexual activity. From baseline to 8 weeks, sildenafil-treated women reported a mean improvement of 1.9 points on a global sexual function scale (range, 1-7 points) compared with 1.1 points for those who received placebo — a statistically and clinically significant difference.
Female Sexual Dysfunction—Medical and Psychological Treatments, Committee 14
Only 28% of sildenafil-treated women noted no improvement, compared with 73% of those who received placebo. Treatment also resulted in significant improvement in ability to achieve orgasm as measured on three additional scales, as well as near-significant improvements in several measures of satisfaction and enjoyment. Significant nitric oxide (NO) and NO synthase activity has been found in female genital tissue, suggesting a plausible biological explanation for how drugs such as sildenafil, which are used in erectile dysfunction, could also affect female sexual function. These results are more positive than those in prior studies, so further replication will be required before these drugs can be recommended for off-label use. CLICK HERE for Journal Watch subscription information.
A Note on Gender and Sex Terminology
2008;7(7) © 2008 Massachusetts Medical Society Cite this: Sildenafil and Sexual Dysfunction in Women Who Take Antidepressants - Medscape - Jul 23, 2008. Study design: Double-blind, placebo-controlled, flexible-dose study. Objective: To evaluate the efficacy, safety and tolerability of oral sildenafil in women with female sexual arousal disorder as a result of SCI (paraplegia/tetraplegia). Setting: The study was conducted at clinical practice sites in North America (n ¼ 23), 11 European countries (n ¼ 23), Australia (n ¼ 4) and South Africa (n ¼ 2). Methods: 129 women were randomized and treated with sildenafil or matching placebo. Female Sexual Arousal Disorder is characterized by a persistent or recurrent inability to attain or maintain sufficient sexual excitement, causing personal distress.
- The use of sildenafil in women is still under scientific investigation.
- Some women report benefits, but evidence is not definitive.
- Potential risks must be carefully weighed against benefits.
- Proper medical guidance is essential for safe use.
This condition can significantly impact a woman's quality of life and intimate relationships.
- Sildenafil’s interaction with other medications is an important consideration.
- It has a different impact depending on individual health conditions.
- Data on long-term effects of sildenafil in women are inconclusive.
- Use only under medical supervision to minimize risks.
The nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway, which plays a crucial role in penile erection, is also believed to be involved in the female sexual arousal response. This has led researchers to explore the potential of sildenafil citrate in treating FSAD. A study aimed at evaluating the efficacy and safety of sildenafil citrate in women with sexual dysfunction, including FSAD, provides valuable insights into this potential treatment option1. The study involved 577 estrogenized and 204 estrogen-deficient women who were randomized to receive either sildenafil (10-100 mg) or a placebo.
Ethics declarations
The Sexual Function Questionnaire, the Sexual Quality of Life Questionnaire-Female, a global efficacy question and Sexual Distress Question were also assessed. Results: Sildenafil-treated women and placebo-treated women had an increase in their percentage of sexual activities throughout the course of the study, with no statistically significant difference between groups in the percentage of successful sexual activities at end of treatment versus baseline. There were also no statistically significant differences between sildenafil-and placebo-treated women on the aforementioned measures. Conclusion: The results of this study are similar to other reports regarding a lack of clinically meaningful benefit of sildenafil in other populations of women. Targeting recovery: priorities of the spinal cord- injured population.
Exclusion Criteria
Sexual activities, response and satisfac- tion in women pre-and post-spinal cord injury. Sexual activities, desire, and satisfaction in males pre-and post-spinal cord injury. Arch Sex Behav 1993; 22: 217-228. Sipski ML, Alexander CJ, Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury.
Anatomy and physiology of female sexual function and dysfunction: classification
Arch Sex Behav 2004; 33: 295-302. Hultling C, Giuliano F, Quirk F, Pen ˜a B, Mishra A, Smith MD. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2002; 11: 277-289. The efficacy was assessed using various tools, including global efficacy questions (GEQ), the Life Satisfaction Checklist (LSC), sexual activity event logs, and a 31-item sexual function questionnaire (SFQ). The study's results indicated that there were no significant differences in efficacy between sildenafil and placebo for any of the measured endpoints, including the GEQ, sexual event logs, LSC, and SFQ1. This suggests that sildenafil did not significantly improve the sexual response in women with FSAD, regardless of their estrogen status. Additionally, the main adverse events reported were headache, flushing, rhinitis, nausea, visual disturbances, and dyspepsia, which were generally mild to moderate in nature.
